What is BPC-157? Research Peptide Guide UK. BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It has been studied extensively in preclinical research for its effects on tissue repair, angiogenesis, and gastrointestinal biology. This guide covers what researchers need to know about BPC-157, its mechanisms of interest, and what to look for when sourcing it for laboratory use.
What is BPC-157?
BPC-157 is a 15-amino acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) first isolated from human gastric juice. Unlike many peptides studied in isolation, BPC-157 has demonstrated stability in human gastric juice, which has made it a subject of interest in gastrointestinal research. It is classified as a research compound and is not approved for human therapeutic use.
Mechanisms of Research Interest
BPC-157 has been studied for its interactions with several biological pathways:
- Growth hormone receptor interactions — BPC-157 has been shown in preclinical models to modulate growth hormone receptor expression, which may influence downstream tissue repair signalling.
- Nitric oxide (NO) pathway — Research suggests BPC-157 may influence nitric oxide synthesis, which plays a role in vascular tone, wound healing, and inflammation modulation.
- VEGF expression — Studies have explored BPC-157’s effects on vascular endothelial growth factor (VEGF), a key mediator of angiogenesis and tissue vascularisation.
- Tendon and ligament biology — Preclinical studies have investigated BPC-157 in models of tendon-to-bone healing and ligament repair.
Areas of Scientific Interest
- Tendon and ligament repair biology
- Gastrointestinal mucosal healing models
- Angiogenesis and VEGF pathway research
- Muscle and bone tissue repair
- Nitric oxide signalling pathways
- Growth hormone receptor interactions
- Neuroprotection and CNS repair models
BPC-157 in Preclinical Research
The majority of BPC-157 research has been conducted in rodent models. Studies have examined its effects across a wide range of tissue types — including tendon, muscle, bone, gut epithelium, and neural tissue. Researchers have noted its apparent systemic activity when administered both locally and systemically in animal models, which has generated interest in its potential as a research tool across multiple biological systems.
It is important to note that BPC-157 has not completed human clinical trials and all findings to date are preclinical. Researchers should consult primary literature and exercise appropriate scientific rigour when designing studies.
What to Look for When Sourcing BPC-157
For laboratory research, purity and documentation are critical. When sourcing BPC-157, researchers should verify:
- Purity ≥99% — confirmed by HPLC analysis
- Certificate of Analysis (CoA) — batch-specific documentation from an independent laboratory
- Lyophilised format — for stability during storage and shipping
- Research-use-only labelling — confirming the compound is not intended for human or veterinary use
Research Use Only
BPC-157 is supplied strictly for in-vitro and laboratory research purposes. It is not intended for human consumption, therapeutic use, or veterinary use. Researchers are responsible for compliance with all applicable regulations in their jurisdiction.
Source BPC-157 for research: BPC-157 10mg Research Peptide — ≥99% purity, HPLC-verified, UK-dispatched. Also available: TB-500 10mg and Klow 80mg (BPC-157 + TB-500 blend). Related guides: What is TB-500? | What is Klow? | BPC-157 vs TB-500 Comparison.
0 comments